Twin Peaks Wealth Advisors, LLC Collegium Pharmaceutical, Inc Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 62 shares of COLL stock, worth $2,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62Holding current value
$2,097% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
241Shares Held
36.4MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$196 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$107 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$89.4 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$76.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$53.6 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.15B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...